The tweet was deleted by the author.
But we saved everything 🙂.
Cathie Wood, fund manager at ARK Invest, highlights that Christian Angermayer is selling his psychedelic biotech company ATAI for approximately $3.8 billion to Lilly, the largest biotech company in the world.
Wood notes that this transaction marks a well-deserved return for ATAI shareholders and validates the mission and vision of the company.
Wood has previously noted that capital outflows from unstable countries can increase demand for bitcoin and digital assets, according to a recent article on crypto markets. She has also argued that the U.S. Federal Reserve is likely to support economic growth if inflation falls to 0–1%, as outlined in a separate commentary. These views highlight her ongoing focus on market responses to major economic events.